Federal Trade Commission Takes Action Against Stem Cell Clinics
The FTC, in its first crack down on the industry, gets two California companies selling unproven treatments to stop their false advertising and pay a fine. (Source: The Scientist)
Source: The Scientist - October 19, 2018 Category: Science Tags: News & Opinion Source Type: news

Medical News Today: What are stem cells, and what do they do?
Stem cells are basic cells that can become almost any type of cell in the body. Human stem cells can come from an embryo or an adult human. They have many possible uses in science and medicine, yet controversy surrounds them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 19, 2018 Category: Consumer Health News Tags: Stem Cell Research Source Type: news

$5.1 million grant will fund research to develop stem cell-based therapy for blinding eye conditions
Scientists at the UCLA  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.The award by the California Institute for Regenerative Medicine, or CIRM, will support the development of a treatment that will use patients ’ own skin cells to generate autologous induced pluripotent stem cells to derive retinal pigment epithelium cells, which are lost in many blinding eye conditions....
Source: UCLA Newsroom: Health Sciences - October 19, 2018 Category: Universities & Medical Training Source Type: news

Journal Fallout Over Controversial Stem Cell Doc's Research Journal Fallout Over Controversial Stem Cell Doc's Research
Just days after his former institution called for journals to retract 31 of his papers, one prominent journal has started the ball rolling.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 18, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

U Penn trial regrows dental pulp from baby tooth stem cells
Data from recent clinical trial out of the University of Pennsylvania suggest that the use of stem cells from a patient’s baby teeth could be used to help regrow dental pulp tissue. Results from the trial, which was conducted in China, were published in the journal Science Translational Medicine. In the trial, 40 children were selected who had injured a permanent incisor but still had baby teeth, with 30 assigned to the experimental treatment and 10 to the controlled treatment with the standard of care, apexification. The stem cells, officially known as human deciduous pulp stem cells (hDPSC), are extracted from heal...
Source: Mass Device - October 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Dental Regenerative Medicine University of Pennsylvania Source Type: news

First esophagus grown from stem cells transplanted into mice
Researchers for the first time have grown a functional esophagus from stem cells and transplanted the food pipe successfully in mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 18, 2018 Category: Consumer Health News Source Type: news

Miami biotech receives $3.8M grant
A Miami-based biopharmaceutical company researching antidotes for aging-related diseases has received a $3.8 million grant. Longeveron LLC, founded in 2014, will use the new funding from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant toward developing stem cell therapies for aging frailty, a physiological decline from aging that the company says heightens vulnerability to advers e and serious health conditions in older people. The syndrome affects 10 percent… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 18, 2018 Category: Biotechnology Authors: Emon Reiser Source Type: news

Miami biotech receives $3.8M grant
A Miami-based biopharmaceutical company researching antidotes for aging-related diseases has received a $3.8 million grant. Longeveron LLC, founded in 2014, will use the new funding from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant toward developing stem cell therapies for aging frailty, a physiological decline from aging that the company says heightens vulnerability to advers e and serious health conditions in older people. The syndrome affects 10 percent… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 18, 2018 Category: Health Management Authors: Emon Reiser Source Type: news

PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
SALT LAKE CITY, Oct. 18, 2018 -- (Healthcare Sales & Marketing Network) -- PolarityTE, Inc. (Nasdaq: PTE), a commercial stage biotechnology company focused on transforming the lives of patients by discovering, designing and developing a range of regenerat... Regenerative Medicine, Personnel PolarityTE, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2018 Category: Pharmaceuticals Source Type: news

Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues
Study shows significant improvement in orthopedic healing process Dr. Shai Yarkoni, Company CEO : "Cellect shows promise of ApoGraft™ technology in use for orthopedic indications treated by fat-derived stem cells. Such stem cell enrichment products... Regenerative Medicine, Orthopaedic Cellect Biotechnology, ApoGraft, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2018 Category: Pharmaceuticals Source Type: news

$5.1 million grant will fund research to develop a stem cell-based therapy for blinding eye condition
(University of California - Los Angeles Health Sciences) Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2018 Category: International Medicine & Public Health Source Type: news

Stem cell biologist Sean Morrison elected to the National Academy of Medicine
(UT Southwestern Medical Center) UT Southwestern Professor Dr. Sean Morrison, Director of the Children's Medical Center Research Institute (CRI) at UT Southwestern, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2018 Category: International Medicine & Public Health Source Type: news

Generation of human oogonia from induced pluripotent stem cells in vitro
Human in vitro gametogenesis may transform reproductive medicine. Human pluripotent stem cells (hPSCs) have been induced into primordial germ cell–like cells (hPGCLCs); however, further differentiation to a mature germ cell has not been achieved. Here, we show that hPGCLCs differentiate progressively into oogonia-like cells during a long-term in vitro culture (approximately 4 months) in xenogeneic reconstituted ovaries with mouse embryonic ovarian somatic cells. The hPGCLC-derived oogonia display hallmarks of epigenetic reprogramming—genome-wide DNA demethylation, imprint erasure, and extinguishment of aberrant...
Source: ScienceNOW - October 18, 2018 Category: Science Authors: Yamashiro, C., Sasaki, K., Yabuta, Y., Kojima, Y., Nakamura, T., Okamoto, I., Yokobayashi, S., Murase, Y., Ishikura, Y., Shirane, K., Sasaki, H., Yamamoto, T., Saitou, M. Tags: Development reports Source Type: news

Supracellular contraction at the rear of neural crest cell groups drives collective chemotaxis
Collective cell chemotaxis, the directed migration of cell groups along gradients of soluble chemical cues, underlies various developmental and pathological processes. We use neural crest cells, a migratory embryonic stem cell population whose behavior has been likened to malignant invasion, to study collective chemotaxis in vivo. Studying Xenopus and zebrafish, we have shown that the neural crest exhibits a tensile actomyosin ring at the edge of the migratory cell group that contracts in a supracellular fashion. This contractility is polarized during collective cell chemotaxis: It is inhibited at the front but persists at...
Source: ScienceNOW - October 18, 2018 Category: Science Authors: Shellard, A., Szabo, A., Trepat, X., Mayor, R. Tags: Cell Biology, Development reports Source Type: news

As Part of the Evolving CiPA Paradigm, the FDA Publishes Results...
Working in concert with ACEA Biosciences, the xCELLigence RTCA CardioECR system was employed in the first large-scale multisite study to demonstrate the utility of human induced pluripotent stem cell...(PRWeb October 18, 2018)Read the full story at https://www.prweb.com/releases/as_part_of_the_evolving_cipa_paradigm_the_fda_publishes_results_validating_the_utility_of_hipsc_cardiomyocytes_to_detect_drug_induced_proarrhythmia/prweb15850954.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2018 Category: Pharmaceuticals Source Type: news

Harvard Calls for Retraction of Dozens of Studies by Noted Cardiac Researcher
Some 31 studies by Dr. Piero Anversa contain fabricated or falsified data, officials concluded. Dr. Anversa popularized the idea of stem cell treatment for damaged hearts. (Source: NYT Health)
Source: NYT Health - October 17, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Anversa, Piero Falsification of Data Harvard Medical School Brigham and Women's Hospital Research Heart Stem Cells Clinical Trials Academic and Scientific Journals Source Type: news

Illinois scientists find stem cell proliferation is controlled directly by nervous system
(University of Illinois College of Agricultural, Consumer and Environmental Sciences) Somatic stem cells are microscopic workhorses, constantly regenerating cells throughout the body: skin and the lining of the intestine, for example. And to University of Illinois neuroscientists, they represent untapped potential. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

New Light Shed on HIV-1 Reservoir Reductions After Stem Cell Transplant New Light Shed on HIV-1 Reservoir Reductions After Stem Cell Transplant
Several factors underlie a profound reduction in the HIV-1 reservoir in patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT) for hematologic disease, researchers report.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 16, 2018 Category: Allergy & Immunology Tags: HIV/AIDS News Source Type: news

Mexico's U.S. Drug Problem; 31 Stem Cell Retractions; Hospice Fraud
(MedPage Today) -- The past week in healthcare investigations (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 16, 2018 Category: Psychiatry Source Type: news

Harvard Calls for Retraction of Dozens of Studies by Noted Cardiologist
Some 31 studies by Dr. Piero Anversa contain fabricated or falsified data, officials concluded. Dr. Anversa popularized the idea of stem cell treatment for damaged hearts. (Source: NYT Health)
Source: NYT Health - October 16, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Anversa, Piero Falsification of Data Harvard Medical School Brigham and Women's Hospital Research Heart Stem Cells Clinical Trials Academic and Scientific Journals Source Type: news

Calls to Retract 31 Papers by Disgraced Cardiac Stem Cell Doc Calls to Retract 31 Papers by Disgraced Cardiac Stem Cell Doc
Citing a need for rigorous research practices, Harvard University and Brigham& Women's Hospital are calling for the retraction of 31 papers by a former researcher and professor.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Multidisciplinary team to develop stem cell-based approaches to restore vision
(University of Pennsylvania) Gene therapies have had success in treating blindness but can't save areas of the retina where cells have already died. In a new effort, University of Pennsylvania scientists John Wolfe, also of CHOP, and William Beltran, along with David Gamm of the University of Wisconsin-Madison, will attempt to develop a stem-cell-based approach that restores vision. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2018 Category: International Medicine & Public Health Source Type: news

Researchers use brain cells in a dish to study genetic origins of schizophrenia
(Elsevier) A study in Biological Psychiatry has established a new analytical method for investigating the complex genetic origins of mental illnesses using brain cells that are grown in a dish from human embryonic stem cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2018 Category: International Medicine & Public Health Source Type: news

A human brain model in a petri dish?
(Case Western Reserve University) Researchers are now able to investigate the structural, cellular, and developmental intricacies of the human brain using bioengineered stem cell-based models called organoids. But ethics to help guide researchers and regulators lag behind the technological capability to 'grow' brains. A group of bioethicists and scientists will chart unexplored territory of neuroethics in a study called " The Brainstorm Project, " led by Insoo Hyun, Ph.D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2018 Category: International Medicine & Public Health Source Type: news

Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
Vascular endothelial growth factor (VEGF) stimulates endothelial cells to promote both developmental and pathological angiogenesis. VEGF also directly affects tumor cells and is associated with the initiation, progression, and recurrence of tumors, as well as the emergence and maintenance of cancer stem cells (CSCs). Studies have uncovered the importance of the transcriptional regulators YAP and TAZ in mediating VEGF signaling. For example, VEGF stimulates the GTPase activity of Rho family members and thereby alters cytoskeletal dynamics, which contributes to the activation of YAP and TAZ. In turn, YAP- and TAZ-mediated ch...
Source: Signal Transduction Knowledge Environment - October 16, 2018 Category: Science Authors: Elaimy, A. L., Mercurio, A. M. Tags: STKE Reviews Source Type: news

New connections: VEGF beyond the vasculature
The growth factor VEGF promotes cancer-associated stem cell biology and pain, as well as angiogenesis. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - October 16, 2018 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Fecal transplants restore gut microbes after antibiotics
Using fecal transplants, researchers restored beneficial bacteria in cancer patients who received antibiotics for stem cell transplant procedures. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 15, 2018 Category: Consumer Health News Source Type: news

Scientists Use Stem Cells and Gene Editing to Make Mice With Two Mums Scientists Use Stem Cells and Gene Editing to Make Mice With Two Mums
Chinese scientists said on Thursday they had used gene editing and stem cell techniques to produce healthy mice with two mothers which developed well enough to go on to have normal offspring of their own.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - October 15, 2018 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Dozens of Retractions Requested for Heart Stem Cell Studies
Harvard and Brigham and Women's Hospital disavow the work by former faculty member Piero Anversa. (Source: The Scientist)
Source: The Scientist - October 15, 2018 Category: Science Tags: News & Opinion Source Type: news

Stem Cell Transplant Effective as First Line in Aggressive MS Stem Cell Transplant Effective as First Line in Aggressive MS
Stem cell treatment for MS is now becoming safe and highly effective for certain patients with very active disease, latest data suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Trilobites: Watch This Blob of Cells Become an Embryo in High-Resolution
Researchers developed a new microscope that traces embryonic cell movement in real time, sketching a virtual map of how organ systems develop. (Source: NYT Health)
Source: NYT Health - October 15, 2018 Category: Consumer Health News Authors: EMILY BAUMGAERTNER Tags: Microscopes Reproduction (Biological) Research Microbiology Mice Cell (Journal) Birth Defects Stem Cells (Embryonic) McDole, Kate Source Type: news

Media Advisory: The New York Stem Cell Foundation Conference
(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF)'s 13th annual translational stem cell research conference convenes global leaders in stem cell research to present their latest progress towards new treatments and cures for the most devastating diseases and injuries in the world. The two-day conference will feature discussions on transformative new technologies in the field, moving research from the lab to the clinic, and current challenges facing regenerative medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Human brain cell transplant offers insights into neurological conditions
In the new study, MRC funded researchers for the first time successfully transplanted disease-specific human brain cells, created from stem cells, into a mouse brain and watched how they grew and connected to each other. (Source: Medical Research Council General News)
Source: Medical Research Council General News - October 12, 2018 Category: Research Source Type: news

Salivary gland tissue grown from embryonic stem cells
For the first time, researchers have grown three-dimensional salivary gland tissue that produces saliva like normal glands when implanted into mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2018 Category: Consumer Health News Source Type: news

Cancer stem cells use normal genes in abnormal ways
CDK1 is a "normal" protein - its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well - they present bits of proteins on the surfaces of cells for examination by the immune system. But a University of Colorado Cancer Center study published in the journal Cancer Research shows that a population of cancer cells marked by MHC Class I molecules and high CDK1 is anything but normal. (Source: World Pharma News)
Source: World Pharma News - October 12, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

A step in the right direction: could implants help people walk again? – Science Weekly podcast
Four people with paraplegia were recently implanted with electrodes in their lower backs. They all regained movement below their injuries, and two walked again. This weekNicola Davis investigates this technique – epidural stimulation – and other approaches for treating spinal cord injuriesJeff Marquis was spending his day off work on his bike on a mountain trail in Montana. After he landed a jump badly, he realised he could no longer move his legs. He was eventually diagnosed with a spinal cord injury, and doctors told him that he would never walk again.Fast-forward to 2018, and Marquis is now taking steps for ...
Source: Guardian Unlimited Science - October 12, 2018 Category: Science Authors: Presented by Nicola Davis and produced by Geoff Marsh Tags: Science Medicine Stem cells Medical research Biology Source Type: news

Cancer stem cells use normal genes in abnormal ways
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study shows that CDK1 directly interacts with Sox2 to keep cancer cells 'stemmy.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 12, 2018 Category: International Medicine & Public Health Source Type: news

Scientists See a Treatment for Vision Loss in Lab-Grown Retinas
Researchers at Johns Hopkins University are exploring new treatments for vision loss after growing human retinas from scratch, according to a new paper published in the journal Science. The project advances scientists’ understanding of both retinal cell development and color vision, and it paves the way for potential treatments for vision disorders of all kinds. “Our goal is to ultimately provide a way to grow retinas that can be transplanted, or stem cells that we can use for therapy, as a way to replace certain defective parts that lead to vision loss,” says Robert Johnson, a developmental biologist at ...
Source: TIME: Health - October 11, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Research Source Type: news

Liveyon, LLC Issues a Voluntary Nationwide Recall of the Regen Series ® Product, Manufactured by Genetech, Inc.
Liveyon, LLC ( “ Liveyon ” ) is a distributor of stem cell products manufactured by Genetech, Inc. ( “ Genetech ” ), a laboratory located in San Diego, CA. Liveyon marketed and distributed these products under the trade name ReGen Series ® . Liveyon has voluntarily recalled all ReGen Series ® products due to reported possible adverse reactions. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 10, 2018 Category: Food Science Source Type: news

Liveyon, LLC Issues a Voluntary Nationwide Recall of the Regen Series ® Product, Manufactured by Genetech, Inc.
Liveyon, LLC ( “Liveyon”) is a distributor of stem cell products manufactured by Genetech, Inc. (“Genetech”), a laboratory located in San Diego, CA. Liveyon marketed and distributed these products under the trade name ReGen Series®. Liveyon has voluntarily recalled all ReGen Series® products due to repor ted possible adverse reactions. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 10, 2018 Category: Food Science Source Type: news

Creating custom brains from the ground up
(Boston Children's Hospital) In today's Nature, scientists from Boston Children's Hospital and UC San Francisco describe a new way to create customized mouse models for studying the brain. After killing off young brain cells, the developing forebrain can then be reconstituted from genetically engineered stem cells containing the specific genetic modifications desired for study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Scientists mimic the earliest stages of human development
(Gladstone Institutes) Scientists at the Gladstone Institutes have modeled the first step in human development in a laboratory with the goal of better understanding how organs form. In the new study published in eLife, the researchers edited groups of human pluripotent stem cells to silence genes important for cellular mechanics. The alterations prompted the cells to move around and self-organize until they were divided into two groups: Those that had been manipulated and those that had not. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 9, 2018 Category: International Medicine & Public Health Source Type: news

The protein kinase p38{alpha} destabilizes p63 to limit epidermal stem cell frequency and tumorigenic potential
The molecular circuitry directing tissue development and homeostasis is hardwired by genetic programs but may also be subject to fine-tuning or major modification by environmental conditions. It remains unclear whether such malleability is at work—particularly in tissues directly in contact with the environment—and contributes to their optimal maintenance and resilience. The protein kinase p38α is activated by physiological cues that signal tissue damage and neoplastic transformation. Here, we found that p38α phosphorylated and thereby destabilized p63, a transcription factor essential for epidermal...
Source: Signal Transduction Knowledge Environment - October 9, 2018 Category: Science Authors: Choo, M.-K., Kraft, S., Missero, C., Park, J. M. Tags: STKE Research Articles Source Type: news

Umbilical cord blood could be used to fix babies' cleft palates
Stem cells harvested from the umbilical cord blood of nine babies at the Hospital De San Jose in Bogota, Colombia, were used to repair the children's cleft palates in a study which began 10 years ago. (Source: the Mail online | Health)
Source: the Mail online | Health - October 5, 2018 Category: Consumer Health News Source Type: news

UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms
UCLA researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung. These shared molecular mechanisms could lead to the development of drugs to treat not just prostate and lung cancers, but small cell cancers of almost any organ.The key finding: Prostate and lung cells have very different patterns of gene expression when they ’re healthy, but almost identical patterns when they transform into small cell cancers. The research suggests that different types of small cell tumors evolve similarly, even when they come from different organs.The study, led by Dr. O...
Source: UCLA Newsroom: Health Sciences - October 4, 2018 Category: Universities & Medical Training Source Type: news

Study: Lab-grown tissues less effective because stem cells determine fate
Because cells choose their own fate, tissues grown in the lab from stem cells may not offer therapeutic promise, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 4, 2018 Category: Consumer Health News Source Type: news

Mouse Stem Cells Made to Form Embryo-Like Structures
With just a molecular nudge, aggregates of embryonic stem cells take shape as a "gastroloid" bearing the genetic hallmarks and spatial organization of early development. (Source: The Scientist)
Source: The Scientist - October 3, 2018 Category: Science Tags: News & Opinion Source Type: news

Human skeletal stem cell identified
This study may one day lead to ways to restore bone, cartilage, and supportive tissues for organs. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 1, 2018 Category: Consumer Health News Source Type: news

NIDCR Science News - September 2018
Having trouble viewing this email? View it as a Web page. Autotherapies: New Opportunities in Regenerative Medicine NIDCR Director Dr. Martha Somerman and coauthors outline research advances based on the body’s innate healing abilities. NIDCR • September 27, 2018   Clear Up This Stem-Cell Mess NIDCR intramural scientist Dr. Pamela Robey coauthors Nature commentary on the scientific pitfalls of using the loosely defined term “mesenchymal stem cell.”...
Source: NIDCR Science News - September 28, 2018 Category: Dentistry Source Type: news

More Canadian clinics are offering unproven stem cell therapies, study finds
Dozens of unlicensed clinics offering stem cell treatments for a wide variety of medical conditions have sprung up in Canada, marketing their services through direct-to-consumer online advertising, a study has found. (Source: CBC | Health)
Source: CBC | Health - September 26, 2018 Category: Consumer Health News Tags: News/Health Source Type: news